1. Quantification of recombinant immunotoxin delivery to solid tumors allows for direct comparison of in vivo and in vitro results
    Emily Mason-Osann et al, 2015, Sci Rep CrossRef
  2. Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism
    William Putzbach et al, 2017 CrossRef
  3. Peptides for tumor-specific drug targeting: state of the art and beyond
    Maurizio Roveri et al, 2017, J. Mater. Chem. B CrossRef
  4. Fate of Antibody-Drug Conjugates in Cancer Cells
    Cécile Chalouni et al, 2018, J Exp Clin Cancer Res CrossRef
  5. Biosilica-enveloped ferritin cage for more efficient drug deliveries
    Mi-Ran Ki et al, 2018, Process Biochemistry CrossRef
  6. Regulation of transferrin receptor-1 mRNA by the interplay between IRE-binding proteins and miR-7/miR-141 in the 3′-IRE stem–loops
    Masaki Miyazawa et al, 2018, RNA CrossRef
  7. Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction.
    Linhua Lan et al, 2018, Cancer Lett CrossRef
  8. Role of transferrin receptor in hepatitis C viral infection
    Quan Liang, 2018 CrossRef
  9. Iron metabolism gene expression and prognostic features of hepatocellular carcinoma
    Ying Shen et al, 2018, J Cell Biochem CrossRef
  10. Transferrin as a thermosensitizer in radiofrequency hyperthermia for cancer treatment
    Hea-Jong Chung et al, 2018, Sci Rep CrossRef
  11. Perturbation of Iron Metabolism by Cisplatin through Inhibition of Iron Regulatory Protein 2.
    Masaki Miyazawa et al, 2019, Cell Chem Biol CrossRef
  12. Iron in the Tumor Microenvironment—Connecting the Dots
    Christa Pfeifhofer-Obermair et al, 2018, Front. Oncol. CrossRef
  13. A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy
    Min Kim et al, 2018, IJMS CrossRef
  14. Impact of early enteral nutrition on intestinal mucosal barrier and nutrition status in advanced esophageal cancer patients undergoing synchronous chemoradiotherapy
    Qing-Qing Mao et al, 2019, WCJD CrossRef
  15. miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma
    Kamesh R. Babu et al, 2019, Sci Rep CrossRef
  16. A novel Iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage
    Jiecheng Ye et al, 2019, Biochemical Pharmacology CrossRef
  17. Sex‐mismatched red blood cell transfusions and mortality: A systematic review and meta‐analysis
    Michelle P. Zeller et al, 2019, Vox Sang CrossRef
  18. Elucidation and structural modeling of CD71 as a molecular target for cell-specific aptamer binding
    Xiaoqiu Wu et al, 2019, J. Am. Chem. Soc. CrossRef
  19. DNA Damage Response After Ionizing Radiation Exposure in Skin Keratinocytes Derived from Human-Induced Pluripotent Stem Cells
    Tomoko Miyake et al, 2019, International Journal of Radiation Oncology*Biology*Physics CrossRef
  20. Generating Giant Membrane Vesicles from Live Cells with Preserved Cellular Properties
    Qiaoling Liu et al, 2019, Research CrossRef
  21. Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis
    David N. O’Dwyer et al, 2019, Am J Respir Crit Care Med CrossRef
  22. CD71 in Gestational Pathology
    Claudio Luchini et al, 2016, Applied Immunohistochemistry & Molecular Morphology CrossRef
  23. 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules
    Kenneth K. Y. Lai et al, 2016, Tumor Biol. CrossRef
  24. Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells
    Qiuyan Wang et al, 2015, PLoS ONE CrossRef
  25. Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts
    Nikki P. Lee et al, 2015, Cancer Chemother Pharmacol CrossRef
  26. A concise review on cancer treatment methods and delivery systems
    Elham Bidram et al, 2019, Journal of Drug Delivery Science and Technology CrossRef
  27. null
    Alena Rudkouskaya et al, 2020 CrossRef
  28. Retrospective study of small pet tumors treated with Artemisia annua and iron
    Mohamed Saeed et al, 2019, Int J Oncol CrossRef
  29. Coexpression of CD71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human Bone Marrow
    Huy Q. Dinh et al, 2020, Immunity CrossRef
  30. CD71+ Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
    Thomas Ho-Yin Leung et al, 2019, Mol Cancer Res CrossRef
  31. Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer
    Lina S. Schneider et al, 2015, Cancer Res CrossRef
  32. Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents
    Pierre V. Candelaria et al, 2021, Front. Immunol. CrossRef
  33. Evaluating Tissue levels of the Eight Trace Elements and Heavy Metals among Esophagus and Gastric Cancer Patients: A Comparison between Cancerous and Non-Cancerous Tissues
    Masoudreza Sohrabi et al, 2021, Journal of Trace Elements in Medicine and Biology CrossRef
  34. Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
    Aneta Cymbaluk-Płoska et al, 2021, Diagnostics CrossRef
  35. Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
    Melissa Johnson et al, 2021, Clin Cancer Res CrossRef
  36. A curcumin-induced assembly of a transferrin nanocarrier system and its antitumor effect
    Guangming Gong et al, 2022, Colloids and Surfaces B: Biointerfaces CrossRef
  37. Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate
    Shweta Singh et al, 2022 CrossRef
  38. Engineering nanosystems to overcome barriers to cancer diagnosis and treatment
    Suhaila O. Alhaj-Suliman et al, 2022, Advanced Drug Delivery Reviews CrossRef
  39. Cell Size as a Primary Determinant in Targeted Nanoparticle Uptake
    Douglas Howard et al, 2022, ACS Appl. Bio Mater. CrossRef
  40. Ferroptosis Induction and YAP Inhibition as New Therapeutic Targets in Gastrointestinal Stromal Tumors (GISTs)
    Marine Delvaux et al, 2022, Cancers CrossRef
  41. Esophagus cancer and essential trace elements
    Xin Yang et al, 2022, Front. Public Health CrossRef
  42. The analysis of the relationship between transferrin receptor 1 (TfR1) and clinical, morphological and immunophenotypic characteristics of breast cancer: retrospective cohort study
    Svetlana V. Chulkova et al, 2022, J. Mod. Onco. CrossRef
  43. Expression of monomorphic HLA-determinants, transferrin receptor 1 (TfR1) in molecular subtypes of breast cancer
    S. V. Chulkova et al, 2022, Rossijskij bioterapevtičeskij žurnal CrossRef
  44. Novel Development of Nanoparticles—A Promising Direction for Precise Tumor Management
    Dengke Zhang et al, 2022, Pharmaceutics CrossRef
  45. Ferroportin depletes iron needed for cell cycle progression in head and neck squamous cell carcinoma
    Benjamin Ross Belvin et al, 2023, Front. Oncol. CrossRef
  46. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma
    Rahul Arora et al, 2023, Cancer Gene Ther CrossRef
  47. Transferrin receptor 1 targeted nanomedicine for brain tumor therapy
    Jianru Li et al, 2023, Biomater. Sci. CrossRef
  48. The impact of biological age of red blood cell on in vitro endothelial activation markers
    Abdulrahman Alshalani et al, 2023, Front. Physiol. CrossRef
  49. Advances in the Theranostics of Oesophageal Squamous Carcinoma
    Miaomiao Cheng et al, 2023, Advanced Therapeutics CrossRef
  50. Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway
    Guofei Feng et al, 2023, Cancer Cell Int CrossRef
  51. Photoactivable liposomes for controlled delivery: Recent progress and design considerations
    Seoyoon Song et al, 2024, Coordination Chemistry Reviews CrossRef
  52. Iron, Copper, and Magnesium Concentration in Hair and Risk of Esophageal Cancer: A Nested Case-Control Study
    Maryam Hashemian et al, 2023, Arch Iran Med CrossRef
  53. Iron, Copper, and Selenium: Cancer's Thing for Redox Bling
    Erdem M. Terzi et al, 2024, Cold Spring Harb Perspect Med CrossRef
  54. An affordable label-free ultrasensitive immunosensor based on gold nanoparticles deposited on glassy carbon electrode for the transferrin receptor detection
    Abrar Ahmad et al, 2024, International Journal of Biological Macromolecules CrossRef
  55. Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers
    Avinash Khadela et al, 2024, Clin Med Insights Oncol CrossRef
  56. Dual-Targeted Zeolitic Imidazolate Frameworks Drug Delivery System Reversing Cisplatin Resistance to Treat Resistant Ovarian Cancer
    Yan Xing et al, 2024, IJN CrossRef
  57. Exploring the interplay between iron metabolism imbalance and esophageal cancer
    Lu Qi et al, 2024 CrossRef
  58. Expression of transferrin receptor 1 and β1-integrins correlates with estrogen receptor status and immune infiltration in breast cancer
    S.V. Chulkova et al, 2024, Rus. J. Arch. Pathol. CrossRef
  59. INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
    Manuela Bratti et al, 2024 CrossRef
  60. A Self‐Catalytic NO/O2 Gas‐Releasing Nanozyme for Radiotherapy Sensitization through Vascular Normalization and Hypoxia Relief
    Shuyu Wang et al, 2024, Advanced Materials CrossRef
  61. SLC39A14 promotes the development of esophageal squamous cell carcinoma through PI3K/Akt/mTOR signaling pathway
    Hangshuai Qu et al, 2025, International Immunopharmacology CrossRef
  62. Iron metabolism and the tumor microenvironment: A new perspective on cancer intervention and therapy (Review)
    Xiaorui Bu et al, 2024, Int J Mol Med CrossRef